TR200003184T2 - '' New serine protease capable of selective cleavage of the protein that binds the insulin-like growth factor '' - Google Patents

'' New serine protease capable of selective cleavage of the protein that binds the insulin-like growth factor ''

Info

Publication number
TR200003184T2
TR200003184T2 TR2000/03184T TR200003184T TR200003184T2 TR 200003184 T2 TR200003184 T2 TR 200003184T2 TR 2000/03184 T TR2000/03184 T TR 2000/03184T TR 200003184 T TR200003184 T TR 200003184T TR 200003184 T2 TR200003184 T2 TR 200003184T2
Authority
TR
Turkey
Prior art keywords
insulin
binds
protein
growth factor
serine protease
Prior art date
Application number
TR2000/03184T
Other languages
Turkish (tr)
Inventor
P. Smeekens Steven
Hou Jinzhao
Original Assignee
Axys Pharmaceuticals, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axys Pharmaceuticals, Inc filed Critical Axys Pharmaceuticals, Inc
Publication of TR200003184T2 publication Critical patent/TR200003184T2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes

Abstract

Bu bulus, bir ASPO5 proteazi ile sekans/dizi idantitesine sahip olan yeni nükleik asitlere ve proteinlere, ve bu gibi kompozisyonlarin deneylerde/analizlerde, ve de hastaligin teshis ve tedavisinde kullanimina yönelmistir.This invention is directed to new nucleic acids and proteins with sequence / sequence identity with an ASPO5 protease, and the use of such compositions in experiments / analyzes, and in the diagnosis and treatment of the disease.

TR2000/03184T 1998-04-28 1999-04-28 '' New serine protease capable of selective cleavage of the protein that binds the insulin-like growth factor '' TR200003184T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8332198P 1998-04-28 1998-04-28
US30062199A 1999-04-27 1999-04-27

Publications (1)

Publication Number Publication Date
TR200003184T2 true TR200003184T2 (en) 2001-03-21

Family

ID=26769169

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03184T TR200003184T2 (en) 1998-04-28 1999-04-28 '' New serine protease capable of selective cleavage of the protein that binds the insulin-like growth factor ''

Country Status (6)

Country Link
JP (1) JP2003517269A (en)
KR (1) KR20010043127A (en)
CA (1) CA2327352A1 (en)
IL (1) IL139309A0 (en)
NO (1) NO20005455D0 (en)
TR (1) TR200003184T2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102277471B1 (en) * 2019-10-22 2021-07-14 주식회사 지니스 Thrombolytic agents for Intravascular clots
KR102362115B1 (en) * 2019-10-22 2022-02-14 주식회사 지니스 Thrombolytic agents for Intravascular clots

Also Published As

Publication number Publication date
NO20005455D0 (en) 2000-10-27
JP2003517269A (en) 2003-05-27
IL139309A0 (en) 2001-11-25
CA2327352A1 (en) 1999-11-04
KR20010043127A (en) 2001-05-25

Similar Documents

Publication Publication Date Title
TR200601231T2 (en) Secretion of Alzheimer's disease.
NO971875L (en) Cathepsin 02 protease
BR0213786A (en) Effective peptides in treating tumors and other conditions requiring cell removal or destruction
TR200003181T2 (en) FAP alpha specific antibody with improved reproducibility
EE03693B1 (en) Isolated dimeric fibroblast activation protein alpha and its uses
EA199900355A1 (en) TELOMERASE REVERSE TRINCRYPTASE
ES2121479T3 (en) STABILIZING SOLUTION FOR PROTEINS AND PEPTIDES.
DE60144145D1 (en) Subtilisin variant
TR200001709T2 (en) New neisseria meningitids surface protein
DE60132075D1 (en) WNT-1 RELATED POLYPEPTIDES AND NUCLEIC ACIDS THEREFOR
DE59903410D1 (en) HYBRID PROTEIN TO INHIBIT MAST CELL DEGRANULATION AND USE
SE8902532D0 (en) DETERMINATION OF PLASMA PROTEINS
ATE135371T1 (en) PROTEIN ASSOCIATED WITH ACUTE PANCREATITIS, AGENTS FOR DIAGNOSING ACUTE PANCREATITIS
BR0209990A (en) Effective peptides in treating tumors and other conditions requiring cell removal or destruction
ATE443076T1 (en) PROTEASE TYPE II CLAVEABLE PEPTIDE
ATE307205T1 (en) FROZEN FOOD
ATE356207T1 (en) HUMAN BTRCP PROTEIN
TR200201119T2 (en) DNA encoding human alpha1G-C-type calcium channel.
TR200003184T2 (en) '' New serine protease capable of selective cleavage of the protein that binds the insulin-like growth factor ''
WO2001056456A3 (en) Methods and compositions for detection of disease
EA200000875A1 (en) PROTEINS INTERACTING WITH CASPASE-8
PT723552E (en) OLIGOPEPTIDES DERIVED FROM REAGENT PROTEIN FRAGMENTS
ATE344325T1 (en) NEISSERIA LACTOFERRIN-BINDING PROTEIN
WO1999055885A3 (en) Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
TR199902866T2 (en) New BPC peptide salts with organoprotective activity, processes for their preparation and use in therapy.